Paul Gitman, Director at BIOSPECIFICS TECHNOLOGIES CORP (BSTC), sold 24,000 shares at $42.00 ($1.0M) on 2015-05-27, disclosed to the SEC on 2015-05-28.
Scheduled sale ($1.0M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| BSTC | SELL | 2018-08-29 | $945K | — | Filing → |
| BSTC | SELL | 2018-08-29 | $883K | — | Filing → |
| BSTC | SELL | 2015-07-21 | $461K | — | Filing → |